On November 5, 2019, Novelion Therapeutics Inc. announced that the Company held its annual meeting of shareholders on November 5, 2019. In the meeting, the shareholders approved a special resolution authorizing the voluntary liquidation and dissolution of the Company pursuant to the Business Corporations Act at a time to be determined by the board of directors of the Company.